News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,913 Results
Type
Article (57651)
Company Profile (436)
Press Release (649809)
Multimedia
Podcasts (171)
Webinars (23)
Section
Business (184603)
Career Advice (3274)
Deals (32955)
Drug Delivery (139)
Drug Development (83133)
Employer Resources (181)
FDA (16521)
Job Trends (14612)
News (324713)
Policy (32421)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2945)
Academic (1)
Accelerated approval (33)
Adcomms (36)
Allergies (144)
Alliances (47023)
ALS (181)
Alzheimer's disease (1785)
Antibody-drug conjugate (ADC) (345)
Approvals (16708)
Artificial intelligence (557)
Autoimmune disease (162)
Automation (35)
Bankruptcy (333)
Best Places to Work (11760)
BIOSECURE Act (21)
Biosimilars (200)
Biotechnology (308)
Bladder cancer (161)
Brain cancer (64)
Breast cancer (660)
Cancer (5007)
Cardiovascular disease (444)
Career advice (2782)
Career pathing (40)
CAR-T (307)
CDC (59)
Celiac Disease (2)
Cell therapy (828)
Cervical cancer (37)
Clinical research (70436)
Collaboration (1801)
Company closure (5)
Compensation (1127)
Complete response letters (73)
COVID-19 (2924)
CRISPR (99)
C-suite (846)
Cystic fibrosis (155)
Data (6290)
Decentralized trials (2)
Denatured (55)
Depression (150)
Diabetes (526)
Diagnostics (6647)
Digital health (43)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (275)
Drug pricing (218)
Drug shortages (36)
Duchenne muscular dystrophy (241)
Earnings (74866)
Editorial (65)
Employer branding (22)
Employer resources (163)
Events (117795)
Executive appointments (982)
FDA (19673)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1524)
Gene editing (215)
Generative AI (51)
Gene therapy (673)
GLP-1 (1107)
Government (5255)
Grass and pollen (7)
Guidances (376)
Healthcare (19849)
HIV (61)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (60)
Indications (103)
Infectious disease (3207)
Inflammatory bowel disease (205)
Inflation Reduction Act (17)
Influenza (115)
Intellectual property (247)
Interviews (636)
IPO (15848)
IRA (57)
Job creations (3215)
Job search strategy (2256)
JPM (69)
Kidney cancer (15)
Labor market (83)
Layoffs (623)
Leadership (39)
Legal (7149)
Liver cancer (98)
Longevity (15)
Lung cancer (675)
Lymphoma (380)
Machine learning (44)
Management (63)
Manufacturing (827)
MASH (175)
Medical device (13520)
Medtech (13572)
Mergers & acquisitions (18198)
Metabolic disorders (1390)
Multiple sclerosis (162)
NASH (23)
Neurodegenerative disease (354)
Neuropsychiatric disorders (102)
Neuroscience (3106)
Neurotech (1)
NextGen: Class of 2026 (6983)
Non-profit (4878)
Now hiring (63)
Obesity (677)
Opinion (329)
Ovarian cancer (167)
Pain (216)
Pancreatic cancer (227)
Parkinson's disease (299)
Partnered (34)
Patents (501)
Patient recruitment (491)
Peanut (59)
People (56167)
Pharmaceutical (77)
Pharmacy benefit managers (33)
Phase 1 (22005)
Phase 2 (30995)
Phase 3 (23245)
Pipeline (5157)
Policy (330)
Postmarket research (2584)
Preclinical (9496)
Press Release (67)
Prostate cancer (250)
Psychedelics (57)
Radiopharmaceuticals (301)
Rare diseases (920)
Real estate (5579)
Recruiting (76)
Regulatory (24650)
Reports (41)
Research institute (2628)
Resumes & cover letters (520)
Rett syndrome (28)
RNA editing (21)
RSV (84)
Schizophrenia (159)
Series A (257)
Series B (196)
Service/supplier (10)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (3571)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (98)
The Weekly (114)
Vaccines (1110)
Venture capital (98)
Weight loss (462)
Women's health (85)
Worklife (22)
Date
Last 7 days (621)
Last 30 days (2167)
Last 365 days (30870)
2026 (2925)
2025 (31341)
2024 (36274)
2023 (40777)
2022 (51715)
2021 (56272)
2020 (54815)
2019 (48188)
2018 (36561)
2017 (33470)
2016 (32944)
2015 (38039)
2014 (29963)
2013 (24998)
2012 (26604)
2011 (27059)
2010 (24563)
Location
Africa (944)
Alabama (90)
Alaska (7)
Arizona (246)
Arkansas (14)
Asia (41496)
Australia (7250)
California (11189)
Canada (3265)
China (1160)
Colorado (462)
Connecticut (471)
Delaware (332)
Europe (96284)
Florida (1660)
Georgia (354)
Hawaii (3)
Idaho (62)
Illinois (889)
India (67)
Indiana (492)
Iowa (24)
Japan (424)
Kansas (128)
Kentucky (38)
Louisiana (27)
Maine (81)
Maryland (1387)
Massachusetts (8249)
Michigan (319)
Minnesota (629)
Mississippi (5)
Missouri (129)
Montana (31)
Nebraska (28)
Nevada (113)
New Hampshire (79)
New Jersey (3015)
New Mexico (32)
New York (2994)
North Carolina (1506)
North Dakota (10)
Northern California (5411)
Ohio (333)
Oklahoma (22)
Oregon (41)
Pennsylvania (2233)
Puerto Rico (21)
Rhode Island (47)
South America (1261)
South Carolina (63)
South Dakota (1)
Southern California (4363)
Tennessee (159)
Texas (1717)
United States (39982)
Utah (316)
Vermont (1)
Virginia (263)
Washington D.C. (80)
Washington State (942)
West Virginia (4)
Wisconsin (108)
Wyoming (1)
707,913 Results for "the als association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ALS Association Commits $2 Million to Support Early-Stage Clinical Trials of Two Emerging ALS Therapies
December 5, 2025
·
4 min read
Press Releases
Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS
November 26, 2025
·
5 min read
Press Releases
ALS Association Awards Over $2 Million in Grants to Strengthen ALS Care in Local Communities
November 21, 2025
·
3 min read
Press Releases
Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS
December 10, 2025
·
6 min read
ALS
New Wave of ALS Therapies Signals Renaissance After Incremental Regression
After a demoralizing period punctuated by the withdrawal of one of the few marketed therapies for ALS, investment in new biotechs, state-backed collaborative initiatives and buzz at BIO2025 suggest a new day in drug development for one of medicine’s most intractable diseases.
September 2, 2025
·
6 min read
·
Heather McKenzie
Press Releases
MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND
December 8, 2025
·
6 min read
Press Releases
NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s
January 8, 2026
·
3 min read
Press Releases
Coya Therapeutics Receives Clinical Trial Application (CTA) Acceptance from Health Canada to Proceed with the COYA 302 ALSTARS Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
December 24, 2025
·
6 min read
Press Releases
Inflammasome Therapeutics to Collaborate with Sean M. Healey & AMG Center for ALS on a new treatment for Amyotrophic Lateral Sclerosis (ALS)
November 14, 2025
·
4 min read
Press Releases
Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment of ALS and Related Neurodegenerative Diseases
January 9, 2026
·
3 min read
1 of 70,792
Next
